Role of Extracorporeal Membrane Oxygenation in the Treatment of Massive Pulmonary Embolism

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Massive pulmonary embolism (PE) carries a high mortality rate (approx. 65% at 30 days).
• Renewed interest exists in venoarterial (V-A) extracorporeal membrane oxygenation (ECMO) for high-risk PE treatment.
• Current evidence on ECMO for massive PE is limited, primarily from retrospective, small, single-center studies without adequate controls.

Purpose of the Study:

• To review the current evidence and discuss the potential role of V-A ECMO in managing massive PE.
• To highlight the limitations of existing studies and the need for high-quality research.
• To explore specific indications for V-A ECMO in massive PE, including cardiac arrest and contraindications to thrombolysis.

Main Methods:

• Review of existing literature on V-A ECMO for massive PE.
• Discussion of treatment strategies and patient selection criteria.
• Identification of knowledge gaps and future research directions.

Main Results:

• V-A ECMO is increasingly supported for massive PE with cardiac arrest.
• For patients without cardiac arrest but with thrombolysis contraindications, V-A ECMO with anticoagulation can stabilize them.
• Persistent right ventricular dysfunction after 3-5 days of ECMO may warrant embolectomy.

Conclusions:

• High-quality, multicenter, prospective studies are urgently required to establish the definitive role of V-A ECMO in massive PE.
• V-A ECMO can be a temporizing measure in specific high-risk PE scenarios.
• Further research is essential to optimize treatment algorithms and improve outcomes for massive PE.